Rep. April McClain Delaney Purchases Shares of STERIS plc (NYSE:STE)

Posted by Caroline Horne on May 8th, 2026

Representative April McClain Delaney (Democratic-Maryland) recently bought shares of STERIS plc (NYSE:STE). In a filing disclosed on May 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in STERIS stock on April 30th.

Representative April McClain Delaney also recently made the following trade(s):

Sold $1,001 – $15,000 in shares of Service Corporation International (NYSE:SCI) on 4/30/2026.
Purchased $1,001 – $15,000 in shares of Markel Group (NYSE:MKL) on 4/30/2026.
Sold $1,001 – $15,000 in shares of Clean Harbors (NYSE:CLH) on 4/30/2026.
Purchased $1,001 – $15,000 in shares of Transdigm Group (NYSE:TDG) on 4/29/2026.
Purchased $1,001 – $15,000 in shares of Packaging Corporation of America (NYSE:PKG) on 4/29/2026.
Purchased $1,001 – $15,000 in shares of Packaging Corporation of America (NYSE:PKG) on 4/24/2026.
Purchased $1,001 – $15,000 in shares of Nasdaq (NASDAQ:NDAQ) on 4/24/2026.
Sold $1,001 – $15,000 in shares of Fortune Brands Innovations (NYSE:FBIN) on 4/24/2026.
Sold $15,001 – $50,000 in shares of C.H. Robinson Worldwide (NASDAQ:CHRW) on 4/24/2026.
Sold $1,001 – $15,000 in shares of Paychex (NASDAQ:PAYX) on 4/21/2026.

STERIS Stock Down 0.2%

Shares of STERIS stock opened at $214.02 on Friday. STERIS plc has a 12-month low of $195.14 and a 12-month high of $269.44. The firm has a market capitalization of $20.99 billion, a PE ratio of 29.85 and a beta of 0.95. The company has a quick ratio of 1.75, a current ratio of 2.48 and a debt-to-equity ratio of 0.26. The stock’s fifty day moving average is $224.30 and its 200-day moving average is $244.27.

STERIS (NYSE:STE – Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.STERIS’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period last year, the business posted $2.32 earnings per share. Equities analysts anticipate that STERIS plc will post 10.22 earnings per share for the current year.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 8th will be given a dividend of $0.63 per share. The ex-dividend date of this dividend is Monday, June 8th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.2%. STERIS’s payout ratio is 35.15%.

Analysts Set New Price Targets

A number of analysts have commented on STE shares. Weiss Ratings lowered shares of STERIS from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Thursday, April 16th. Wall Street Zen lowered shares of STERIS from a “strong-buy” rating to a “buy” rating in a report on Sunday, April 26th. Five investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $275.20.

Get Our Latest Report on STE

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of STE. Norges Bank acquired a new stake in shares of STERIS during the fourth quarter worth approximately $320,298,000. AQR Capital Management LLC increased its stake in STERIS by 178.6% in the 3rd quarter. AQR Capital Management LLC now owns 1,183,070 shares of the medical equipment provider’s stock valued at $291,704,000 after buying an additional 758,423 shares during the period. Boston Partners acquired a new position in STERIS in the 3rd quarter valued at approximately $158,982,000. Orbis Allan Gray Ltd lifted its position in STERIS by 36.0% in the 2nd quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock worth $504,486,000 after buying an additional 556,088 shares in the last quarter. Finally, Thrivent Financial for Lutherans lifted its position in STERIS by 246.4% in the 3rd quarter. Thrivent Financial for Lutherans now owns 553,834 shares of the medical equipment provider’s stock worth $137,041,000 after buying an additional 393,970 shares in the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.

Insider Activity at STERIS

In other news, Director Cynthia L. Feldmann sold 3,098 shares of the company’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $237.21, for a total value of $734,876.58. Following the transaction, the director directly owned 705 shares of the company’s stock, valued at approximately $167,233.05. This represents a 81.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.07% of the stock is currently owned by corporate insiders.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.

April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

STERIS Company Profile

(Get Free Report)

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.